UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 670

Sortiert nach

In It for the Long Haul: Long-Term Benefit With Adjuvant Endocrine Therapy for Premenopausal Women With Early-Stage Steroid Receptor-Positive Breast Cancer

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4037-4039

Davidson, Nancy E

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2959-2966

2014

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831

Journal of clinical oncology, 2014-11, Vol.32 (33), p.3744-3752

2014

Link zum Volltext

Verfügbarkeit prüfen

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2925-2934

2016

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

Journal of clinical oncology, 2015-08, Vol.33 (23), p.2563-2577

2015

Link zum Volltext

Verfügbarkeit prüfen

The search for ESR1 mutations in breast cancer

Nature genetics, 2013-12, Vol.45 (12), p.1415-1416

2013

Link zum Volltext

Verfügbarkeit prüfen

Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update

Journal of clinical oncology, 2022-08, Vol.40 (23), p.JCO2200520-2655

2022

Link zum Volltext

Verfügbarkeit prüfen

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

Journal of clinical oncology, 2011-09, Vol.29 (25), p.3366-3373

2011

Link zum Volltext

Verfügbarkeit prüfen

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

Journal of clinical oncology, 2015-11, Vol.33 (33), p.3938-3944

2015

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2013-03, Vol.31 (7), p.961-965

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

Journal of clinical oncology, 2015-07, Vol.33 (21), p.2353-2360

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2942-2962

2013

Link zum Volltext

Verfügbarkeit prüfen

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

The New England journal of medicine, 2008-04, Vol.358 (16), p.1663-1671

2008

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3784-3796

2010

Link zum Volltext

Verfügbarkeit prüfen

Updates in endocrine therapy for metastatic breast cancer

Cancer biology & medicine, 2022-02, Vol.19 (2), p.202-212

2022

Link zum Volltext

Verfügbarkeit prüfen

Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines

Molecular cancer therapeutics, 2007-03, Vol.6 (3), p.1013-1021

2007

Link zum Volltext

Verfügbarkeit prüfen

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models

Breast cancer research : BCR, 2017-05, Vol.19 (1), p.60-60, Article 60

2017

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

Frontiers in immunology, 2024-01, Vol.14, p.1325615-1325615

2024

Link zum Volltext

Verfügbarkeit prüfen

Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells

Carcinogenesis (New York), 2013-06, Vol.34 (6), p.1196-1207

2013

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles

Breast cancer research and treatment, 2012-02, Vol.132 (1), p.175-187

2012

Link zum Volltext

Verfügbarkeit prüfen

Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5319-5324

2009

Link zum Volltext

Verfügbarkeit prüfen

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4491-4497

2011

Link zum Volltext

Verfügbarkeit prüfen

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Nature communications, 2019-11, Vol.10 (1), p.5114-5114, Article 5114

2019

Link zum Volltext

Verfügbarkeit prüfen

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Clinical cancer research, 2015-11, Vol.21 (22), p.5082-5091

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 670

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(617)
Mit Volltextzugriff
(606)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(440)
Life Sciences & Biomedicine
(425)
Humans
(423)
Female
(330)
Oncology
(286)
Biological And Medical Sciences
(185)
Medical Sciences
(169)
Breast Neoplasms - Drug Therapy
(167)
Breast Cancer
(145)
Middle Aged
(136)
Tumors
(127)
Adult
(114)
Breast Neoplasms - Pathology
(112)
Aged
(96)
Breast Neoplasms - Genetics
(85)
Breast Neoplasms - Metabolism
(81)
Gynecology. Andrology. Obstetrics
(79)
Mammary Gland Diseases
(77)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(65)
Chemotherapy, Adjuvant
(63)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

In It for the Long Haul: Long-Term Benefit With Adjuvant Endocrine Therapy for Premenopausal Women With Early-Stage Steroid Receptor-Positive Breast Cancer

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

The search for ESR1 mutations in breast cancer

Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Updates in endocrine therapy for metastatic breast cancer

Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models

Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells

Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles

Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Suchergebnisse filtern